These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Fenfluramines, idiopathic pulmonary primary hypertension and cardiac valve disorders: facts and artifacts. Tellier P Ann Med Interne (Paris); 2001 Nov; 152(7):429-36. PubMed ID: 11965083 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for obesity -- do the benefits outweigh the risks? Manson JE; Faich GA N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523 [No Abstract] [Full Text] [Related]
11. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. Mark EJ; Patalas ED; Chang HT; Evans RJ; Kessler SC N Engl J Med; 1997 Aug; 337(9):602-6. PubMed ID: 9271482 [No Abstract] [Full Text] [Related]
12. [Primary vascular pulmonary hypertension and appetite depressants]. Hager W; Thiede D; Wink K Med Klin; 1971 Mar; 66(11):386-90. PubMed ID: 5154284 [No Abstract] [Full Text] [Related]
13. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned? Voelkel NF; Clarke WR; Higenbottam T Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009 [No Abstract] [Full Text] [Related]
14. [Pulmonary hypertension following use of appetite depressants?]. Homann G Med Klin; 1974 Feb; 69(5):211. PubMed ID: 4819931 [No Abstract] [Full Text] [Related]
15. [Drug-clinics. The hue and cry over central appetite suppressants!]. Scheen AJ Rev Med Liege; 1997 Sep; 52(9):613-5. PubMed ID: 9441348 [No Abstract] [Full Text] [Related]